J. Goldman & CO LP Spectrum Pharmaceuticals Inc Call Options Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $4.34 Million - $6.53 Million	263,000 Added 202.31%	393,000 $6.6 Million
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $1.74 Million - $2.64 Million	-121,500 Reduced 48.31%	130,000 $2.73 Million
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $3.36 Million - $5.21 Million	251,500	251,500 $4.77 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.